Genesis Bioventures Announces Letter of Intent for Sales and Distribution of Mad Cow Test Product in China

LOS ANGELES--(BUSINESS WIRE)--Genesis Bioventures, Inc. (GBI) (OTCBB:GBIW) today announced that BioBDC, the Company’s exclusive agent for sales and distribution of Prion Developmental Laboratories’ (PDL) Rapid BSE assay for Mad Cow testing for the Pacific Rim, received a Letter of Intent from Wantai Biological Pharmacy Enterprise Co., Ltd. in Beijing, to sell and distribute the Rapid BSE test kits throughout China.

MORE ON THIS TOPIC